Edition:
United Kingdom

ENDRA Life Sciences Inc (NDRA.OQ)

NDRA.OQ on NASDAQ Stock Exchange Capital Market

2.37USD
20 Apr 2018
Change (% chg)

$0.01 (+0.42%)
Prev Close
$2.36
Open
$2.37
Day's High
$2.37
Day's Low
$2.37
Volume
46
Avg. Vol
5,928
52-wk High
$5.88
52-wk Low
$2.20

Chart for

About

ENDRA Life Sciences Inc. is engaged in commercialization of an enhanced ultrasound technology for the pre-clinical research market. The Company's Nexus 128 system combines light-based thermoacoustics and ultrasound, to address the imaging needs of researchers studying disease models in pre-clinical applications. The Company is... (more)
No analyst recommendations are available for .

Overall

Beta: --
Market Cap(Mil.): $12.93
Shares Outstanding(Mil.): 3.91
Dividend: --
Yield (%): --

Financials

  NDRA.OQ Industry Sector
P/E (TTM): -- 84.02 32.74
EPS (TTM): -1.24 -- --
ROI: -95.41 1.58 14.38
ROE: -95.41 2.41 16.07

BRIEF-Endra Life Sciences Enters Into Amendment To Certain Collaborative Research Agreement With GE

* ENDRA LIFE SCIENCES INC - ON JAN 30, CO ENTERED INTO AMENDMENT TO CERTAIN COLLABORATIVE RESEARCH AGREEMENT WITH GE, DATED AS OF APRIL 22, 2016

05 Feb 2018

BRIEF-ENDRA Life Sciences reports Q3 loss per share $0.23

* Q3 loss per share $0.23 Source text: [http://bit.ly/2ANFlXF] Further company coverage:

15 Nov 2017

Earnings vs. Estimates

No consensus analysis data available.